メインナビゲーションにスキップ
検索にスキップ
メインコンテンツにスキップ
藤田医科大学 ホーム
English
日本語
ホーム
プロファイル
研究部門
研究成果
専門知識、名前、または所属機関で検索
医学部
藤田医科大学
概要
フィンガープリント
ネットワーク
プロファイル
(489)
研究成果
(4198)
フィンガープリント
医学部が活動している研究トピックを掘り下げます。これらのトピックラベルは、この組織のメンバーの研究成果に基づきます。これらがまとまってユニークなフィンガープリントを構成します。
並べ替え順
重み付け
アルファベット順
Medicine and Dentistry
Neoplasm
100%
Percutaneous Coronary Intervention
66%
Surgery
62%
Stomach Cancer
46%
Disease
43%
Malignant Neoplasm
43%
Computer Assisted Tomography
40%
Hepatectomy
39%
Colorectal Cancer
37%
Recurrent Disease
33%
Intravascular Ultrasound
31%
Cohort Analysis
30%
Bleeding
30%
Hazard Ratio
30%
Odds Ratio
29%
Chronic Kidney Disease
28%
Coronary Artery Disease
25%
Acute Coronary Syndrome
25%
Hemodialysis
24%
C Reactive Protein
23%
Cardiovascular System
23%
Aneurysm
22%
Rectum Cancer
22%
Pancreas Cancer
22%
Magnetic Resonance Imaging
22%
Glomerular Filtration Rate
21%
Apoplexy
21%
Retrospective Study
21%
Endoscopic Ultrasound
20%
Drug-Eluting Stent
20%
Stenosis
20%
Observational Study
20%
ST Segment Elevation Myocardial Infarction
20%
Echography
19%
Adenocarcinoma
19%
Overall Survival
19%
Retroperitoneal Lymph Node Dissection
19%
Multivariate Analysis
19%
Survival Rate
19%
Acute Heart Infarction
19%
Lymph Node Metastasis
19%
Myocardial Infarction
18%
Metastatic Carcinoma
18%
Surgeon
18%
Liver Metastasis
18%
Diagnosis
17%
Body Mass Index
16%
Gastrointestinal Stromal Tumor
16%
Adverse Event
16%
Lung Cancer
16%
Hepatocellular Carcinoma
16%
Cardiovascular Disease
16%
Artery
16%
Kidney Function
15%
Cancer
15%
Prevalence
15%
Prospective Study
15%
Endoscopy
15%
Breast Cancer
15%
Cholangiocarcinoma
14%
Gastrectomy
14%
Diabetes Mellitus
14%
Infection
14%
Meta-Analysis
14%
Pediatrics
13%
Systematic Review
13%
Heart Failure
13%
Lymphocyte
13%
Surgical Anastomosis
12%
Multidetector Computed Tomography
12%
Pancreaticoduodenectomy
12%
Intensive Care Unit
12%
Narrow Band Imaging
12%
Hospital Mortality
12%
Prognostic Factor
12%
Clinical Study
12%
Prospective Cohort Study
12%
Optical Coherence Tomography
11%
Major Adverse Cardiac Event
11%
Proteinuria
11%
Symptom
11%
Cross Sectional Study
11%
COVID-19
11%
Carcinoma
11%
Postoperative Complication
11%
Helicobacter Pylori
10%
Bevacizumab
10%
Colon Cancer
10%
Propensity Score Matching
10%
Diabetes
10%
Surgical Technique
10%
Cancer Cell
10%
Heart Muscle Injury
10%
Radiation Therapy
10%
In-Stent Restenosis
10%
Primary Percutaneous Coronary Intervention
10%
Adenoma
10%
Operation Duration
10%
Neck
10%
Biological Marker
10%
Pharmacology, Toxicology and Pharmaceutical Science
Disease
50%
Stomach Cancer
44%
Cohort Study
43%
Chemotherapy
42%
Malignant Neoplasm
30%
Neoplasm
28%
Lipopolysaccharide
27%
Colorectal Cancer
27%
Cardiovascular Disease
25%
C Reactive Protein
25%
Adverse Event
22%
Hemodialysis
21%
Infection
21%
Acute Heart Infarction
21%
Mouse
21%
Prevalence
20%
Heart Infarction
20%
Coronary Artery Disease
19%
Overall Survival
18%
Liver Cell Carcinoma
18%
ST Segment Elevation Myocardial Infarction
17%
Bleeding
17%
Pancreas Cancer
17%
Acute Coronary Syndrome
16%
All Cause Mortality
16%
Observational Study
15%
Combination Therapy
14%
Remission
14%
Biological Marker
14%
Heart Failure
14%
Inflammation
14%
Prospective Study
14%
Bevacizumab
13%
Recurrent Disease
13%
Cytokine
13%
Symptom
12%
Hospital Mortality
12%
Chronic Kidney Failure
12%
Prospective Cohort Study
12%
Clinical Trial
11%
Vasculotropin
11%
Diabetes Mellitus
11%
Tumor Necrosis Factor
11%
Asthma
10%
Lung Cancer
10%
Atherosclerosis
10%
Statin (Protein)
10%
Syndrome
10%
Liver Metastasis
9%
Atrial Fibrillation
9%
Ischemic Heart Disease
9%
Clinical Study
9%
Placebo
9%
Brain Ischemia
9%
Survival Rate
9%
Retrospective Study
9%
Peripheral Occlusive Artery Disease
8%
Serum Albumin
8%
Metastatic Colorectal Cancer
8%
Atezolizumab
8%
Obesity
8%
Clinical Feature
8%
Creatinine
8%
Progression Free Survival
8%
Major Adverse Cardiac Event
7%
Helicobacter Pylori
7%
Nitric Oxide
7%
Paclitaxel
7%
Crohn's Disease
7%
Sepsis
7%
Parkinson's Disease
7%
Imatinib
7%
Diseases
7%
High Density Lipoprotein Cholesterol
6%
Interleukin 6
6%
Rectum Cancer
6%
Colon Cancer
6%
Randomized Clinical Trial
6%
Chronic Obstructive Lung Disease
6%
Mortality Rate
6%
Non Insulin Dependent Diabetes Mellitus
6%
Epileptic Absence
6%
Antiplatelet
6%
Anticoagulant Agent
6%
Cardiovascular Mortality
6%
Ulcer
6%
Acute Heart Failure
6%
Immunotherapy
6%
Acetylsalicylic Acid
6%
Metabolic Syndrome X
6%
Helicobacter Infection
6%
Rapamycin
6%
Fluorouracil
6%
Bloodstream Infection
6%
Ceramide
6%
Gastrointestinal Stromal Tumor
6%
HIV
6%
Ethanol
5%
Cardiovascular Risk
5%
Stenosis
5%
Keyphrases
Japan
34%
Confidence Interval
18%
Gastric Cancer
17%
Percutaneous Coronary Intervention
16%
Lipopolysaccharide
16%
Clinical Outcomes
14%
Lipopolysaccharide-induced
14%
Nitric Oxide Production
11%
Japanese Patients
11%
Hazard Ratio
10%
Chemotherapy
10%
Tumor
10%
Acute Myocardial Infarction
9%
Colorectal Cancer
8%
Ulcerative Colitis
8%
Hemodialysis Patients
8%
Adverse Cardiac Events
7%
Tumor Necrosis Factor-α
7%
Vascular Endothelial Cells
7%
Odds Ratio
7%
Risk Factors
7%
Acute Coronary Syndrome
7%
Japanese Population
6%
Multivariate Analysis
6%
C-reactive Protein Level
6%
R0 Resection
6%
Sirolimus-eluting Stent
6%
Meta-analysis
6%
Adjuvant Chemotherapy
6%
Computed Tomography
6%
Estimated Glomerular Filtration Rate
6%
Atezolizumab Plus Bevacizumab
6%
Interferon-α (IFN-α)
5%
Genotype
5%
Lymph Node Metastasis
5%
Geriatric nutritional Risk Index
5%
Multicenter Cohort Study
5%
Major Depressive Disorder
5%
Long-term Clinical Outcome
5%